Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a new human disease with few effective treatments 1 . …

Background Convalescent plasma (CP) for treatment of severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) has shown preliminary signs of effectiveness in moderate to …

BACKGROUND: Transfusion‐related acute lung injury (TRALI) is an uncommon but serious
transfusion reaction. Studies have shown that the transfusion of HLA and HNA antibodies in …

1. Blanco RA, Cavagnetto C, Wilmott L, et al. The use of hematology analyzer with a new
generation of software as an alternative to flow cytometry for enumerating residual white blood …

Cardiac pacemaker current, if, is generated by hyperpolarization-activated cyclic nucleotide-gated
(HCN) channels. Our previous studies demonstrated that altered tyrosine …

Neonatal alloimmune thrombocytopenia (NAIT) is the most common cause of severe
thrombocytopenia and intracranial hemorrhage in the perinatal period. While the gold standard for …

Crouzon’s disease is a well-known disorder affecting multiple organ systems, specifically a
craniofacial disorder with highly variable penetrance and severity of deformity. Crouzon’s …

ABO antibodies are naturally occurring antibodies that are expected to be present in all
individuals older than 4–6 months of age, who do not have the corresponding A and/or B …

The use of convalescent plasma in coronavirus disease 2019 (COVID‑19) in the general
population has not been shown to have a clear benefit. However, there are limited data …

Objective Insulin antibody (IA)-mediated insulin resistance (IR) is a rare condition for which
immunosuppressive regimens have been described. However, these raise the risk of infection…